Functional and cellular interactions between nitric oxide and prostacyclin

Area of Science:

• Cardiovascular Physiology
• Molecular Pharmacology
• Endothelial Cell Biology

Background:

• Nitric oxide (NO) and prostacyclin (PGI(2)) are key mediators of vascular relaxation.
• Their synergistic effects are crucial for maintaining vascular homeostasis.
• The interplay between NO and PGI(2) synthesis pathways requires further elucidation.

Purpose of the Study:

• To investigate the effect of nitric oxide (NO) on prostacyclin (PGI(2)) production.
• To characterize the molecular mechanisms underlying NO's influence on PGI(2) synthesis.
• To determine the impact of this interaction on coronary vasodilation.

Main Methods:

• Evaluation of NO's effect on arachidonic acid (AA)-induced relaxation and PGI(2) release in perfused hearts.
• Utilizing cultured endothelial cells to study NO's impact on PGI(2) synthesis.
• Employing inhibitors of soluble guanylate cyclase (LY-83,583) and cGMP-dependent protein kinases (H-9).
• Investigating cyclooxygenase-1 (COX-1) activity and associated protein phosphorylation via immunoprecipitation.

Main Results:

• Inhibition of NO synthesis enhanced AA-induced PGI(2) synthesis.
• NO donors (SNAP) reduced PGI(2) production and AA-induced relaxation in coronary circulation.
• SNAP decreased PGI(2) production in endothelial cells, an effect mediated by cGMP-dependent protein kinases.
• A 104-kDa protein associated with COX-1 was phosphorylated by NO via cGMP-dependent protein kinases, inhibiting COX-1 activity.

Conclusions:

• Nitric oxide (NO) inhibits prostacyclin (PGI(2)) synthesis through a cGMP-dependent protein kinase pathway.
• This pathway involves the phosphorylation of a 104-kDa protein associated with cyclooxygenase-1 (COX-1).
• NO-induced inhibition of PGI(2) synthesis contributes to reduced coronary PGI(2)-mediated vasodilation.